Joseph Jurcic, MD

Joseph Jurcic, MD

Oncology New York, NY

Professor of Medicine at Columbia University Medical Center Director, Hematologic Malignancies Section, Div. of Hematology/Oncology New York-Presbyterian Hospital/Columbia University Medical Center


Office Address

  • 161 Fort Washington Ave.
    New York, NY 10032
    Phone: (646) 317-5077
    Fax: (212) 305-8112

Joseph Jurcic, MD

Oncology New York, NY

Professor of Medicine at Columbia University Medical Center Director, Hematologic Malignancies Section, Div. of Hematology/Oncology New York-Presbyterian Hospital/Columbia University Medical Center

Summary

  • I am currently Professor of Medicine at Columbia University Medical Center and Director of the Hematologic Malignancies Section of the Division of Hematology/Oncology. Prior to joining the faculty at Columbia University Medical Center in January, 2013, I was an Attending Physician on the Leukemia Service at Memorial Sloan-Kettering Cancer Center for over 18 years. My main focus is the treatment of acute and chronic leukemias, myeloproliferative neoplasms, and myelodysplastic syndrome. My research interests include acute myeloid leukemia, radioimmunotherapy with alpha and beta particle-emitting radioisotopes, monoclonal antibody therapy for leukemia, the development of novel small molecule inhibitors for leukemia, and the molecular monitoring of minimal residual disease. I am the 2001 recipient of the Louis and Allston Boyer Young Investigator Award for Distinguished Achievement in Biomedical Research from Memorial Sloan-Kettering Cancer Center. I am author or coauthor of more than 80 articles and book chapters, have been the principal investigator on over 25 clinical trials, and regularly lecture at national and international meetings. I serve as a Leukemia Section Editor for The Oncologist.

Clinical Specialties & Interests

  • Oncology: Hematologic
  • Clinical Interests: Acute Myeloid Leukemia; Acute Promyelocytic Leukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; BCR-ABL Positive Chronic Myelogenous Leukemia; Myeloproliferative Disorders; Myelodysplastic Syndromes; Clinical Trials as Topic; Monoclonal Antibodies; Radioimmunotherapy; B-Cell Chronic Lymphocytic Leukemia; Investigational Therapies; Immunotherapy; Targeted Therapies

Education & Medical Training

  • Memorial Sloan-Kettering Cancer CenterMemorial Sloan-Kettering Cancer Center
  • Perelman School of Medicine at the University of PennsylvaniaPerelman School of Medicine at the University of Pennsylvania
  • University of Pittsburgh
  • Washington University/Barnes-Jewish HospitalWashington University/Barnes-Jewish Hospital

Certifications & Licensure

  • NJ State Medical LicenseNJ State Medical License2012 - 2015
  • NY State Medical LicenseNY State Medical License1991 - 2016
  • American Board of Internal MedicineInternal Medicine, 1991
  • American Board of Internal MedicineMedical Oncology, 1995, Current
  • American Board of Internal MedicineHematology, 1998, Current

Awards, Honors, & Recognition

  • New York Magazine: Top DoctorsCastle Connolly, 2014
  • America's Top DoctorsCastle Connolly, 2014, 2013, 2012, 2011, 2010
  • Top Doctors: New York Metro AreaCastle Connolly, 2015, 2014, 2013, 2011, 2010, 2009, 2007

Clinical Trials

Publications & Presentations

PubMed

Books/Book Chapters

  • Clinical Radiation Oncology Chapter: Targeted radionuclide therapy 
    Jurcic JG, Wong JYC, Knox SJ, Wahl D, Rosenblat T, Meredith RF
    Editors: Gunderson LL, Tepper JL.Elsevier, Inc., Philadelphia
    Edition 4,2015
  • Hematological Malignancies in Children, Adolescents and Young Adults Chapter: Childhood, adolescent and young adult acute myeloid leukemias Page 265 - 312
    Arceci RJ, Meshinchi S, Rosenblat TL, Jurcic JG, Tallman MS
    Editors: Cairo MS, Perkins SL.World Scientific Publishing Co., Inc., Singapore
    2012
  • Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer Chapter: Radioimmunotherapy of acute myeloid leukemia Page 219 - 240
    Rosenblat TL, Jurcic JG
    Editors: Reilly R.John Wiley & Sons, Inc, Hoboken
    2010

Lectures

  • Alpha Particle Therapy of Hematologic Malignanices 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Barcelona, Spain - 11/2014
  • Best of ASCO: Leukemia Highlights Boston, MA - 8/2014
  • Radiopharmaceutical: Spanning Hematologic Malignancies to Solid Tumors American Society of Clinical Oncology, 50th Annual Meeting, Chicago, IL - 6/2014

Committees

  • Scientific Program Committee on Leukemia, Myelodysplasia, and Transplantation, American Society of Clinical Oncology Member 2014 - Present
  • Education Committee, Society of Hematologic Oncology Member 2013 - Present
  • Southwest Oncology Group, Leukemia Committee and Leukemia Committee Working Group Member 2013 - Present

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Empire BCBS HMO
  • Empire BCBS PPO
  • GHI PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • MVP Healthcare PPO
  • Oxford Health Freedom
  • Oxford Health Liberty
  • QualCare HMO
  • QualCare PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
  • The full profile is locked and available to verified physicians only.
    Join over 50% of U.S. physicians already on Doximity and get access to this and over 700,000 physician CVs. Find your physician profile

Physicians, view Dr. Jurcic's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV

© 2015 Doximity, Inc.HelpBlogCompanyContactPrivacyDirectory